104 related articles for article (PubMed ID: 38953032)
1. Systemic inflammation biomarkers during angioedema attacks in hereditary angioedema.
Gil-Serrano J; Labrador-Horrillo M; Galvan-Blasco P; Sala-Cunill A; Bigas P; Pereira-González J; Luengo O; Cardona V; Guilarte M
Front Immunol; 2024; 15():1400526. PubMed ID: 38953032
[TBL] [Abstract][Full Text] [Related]
2. Changes of coagulation parameters during erythema marginatum in patients with hereditary angioedema.
Kőhalmi KV; Mező B; Veszeli N; Benedek S; Fehér A; Holdonner Á; Jesenak M; Varga L; Farkas H
Int Immunopharmacol; 2020 Apr; 81():106293. PubMed ID: 32078942
[TBL] [Abstract][Full Text] [Related]
3. Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII).
Bork K; Wulff K; Witzke G; Hardt J
Allergy; 2017 Feb; 72(2):320-324. PubMed ID: 27905115
[TBL] [Abstract][Full Text] [Related]
4. Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients.
Mansi M; Zanichelli A; Coerezza A; Suffritti C; Wu MA; Vacchini R; Stieber C; Cichon S; Cicardi M
J Intern Med; 2015 May; 277(5):585-93. PubMed ID: 25196353
[TBL] [Abstract][Full Text] [Related]
5. sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitor.
Larrauri B; Hester CG; Jiang H; Miletic VD; Malbran A; Bork K; Kaplan A; Frank M
Mol Immunol; 2020 Mar; 119():27-34. PubMed ID: 31955064
[TBL] [Abstract][Full Text] [Related]
6. Hereditary Angioedema with Normal C1 Inhibitor and F12 Mutations in 42 Brazilian Families.
Veronez CL; Moreno AS; Constantino-Silva RN; Maia LSM; Ferriani MPL; Castro FFM; Valle SR; Nakamura VK; Cagini N; Gonçalves RF; Mansour E; Serpa FS; Coelho Dias GA; Piccirillo MA; Toledo E; de Souza Bernardes M; Cichon S; Stieber C; Arruda LK; Pesquero JB; Grumach AS
J Allergy Clin Immunol Pract; 2018; 6(4):1209-1216.e8. PubMed ID: 29128335
[TBL] [Abstract][Full Text] [Related]
7. Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations.
Bork K; Wulff K; Witzke G; Hardt J
Allergy; 2015 Aug; 70(8):1004-12. PubMed ID: 25952149
[TBL] [Abstract][Full Text] [Related]
8. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
9. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema.
Deroux A; Boccon-Gibod I; Fain O; Pralong P; Ollivier Y; Pagnier A; Djenouhat K; Du-Thanh A; Gompel A; Faisant C; Launay D; Bouillet L
Clin Exp Immunol; 2016 Sep; 185(3):332-7. PubMed ID: 27271546
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency.
Csuka D; Veszeli N; Imreh É; Zotter Z; Skopál J; Prohászka Z; Varga L; Farkas H
Orphanet J Rare Dis; 2015 Oct; 10():132. PubMed ID: 26452350
[TBL] [Abstract][Full Text] [Related]
11. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.
Joseph K; Tholanikunnel BG; Wolf B; Bork K; Kaplan AP
J Allergy Clin Immunol; 2016 Jun; 137(6):1822-1829.e1. PubMed ID: 26395818
[TBL] [Abstract][Full Text] [Related]
13. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency.
Suffritti C; Zanichelli A; Maggioni L; Bonanni E; Cugno M; Cicardi M
Clin Exp Allergy; 2014 Dec; 44(12):1503-14. PubMed ID: 24552232
[TBL] [Abstract][Full Text] [Related]
14. Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor.
Moreno AS; Valle SO; Levy S; França AT; Serpa FS; Arcuri HA; Palma MS; Campos WN; Dias MM; Ponard D; Monnier N; Lunardi J; Bork K; Silva WA; Arruda LK
Int Arch Allergy Immunol; 2015; 166(2):114-20. PubMed ID: 25790805
[TBL] [Abstract][Full Text] [Related]
15. Angioedema attacks in patients with hereditary angioedema: Local manifestations of a systemic activation process.
Hofman ZL; Relan A; Zeerleder S; Drouet C; Zuraw B; Hack CE
J Allergy Clin Immunol; 2016 Aug; 138(2):359-66. PubMed ID: 27246526
[TBL] [Abstract][Full Text] [Related]
16. Angioedema Without Wheals: Challenges in Laboratorial Diagnosis.
Grumach AS; Veronez CL; Csuka D; Farkas H
Front Immunol; 2021; 12():785736. PubMed ID: 34956216
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein levels in hereditary angioedema.
Hofman ZL; Relan A; Hack CE
Clin Exp Immunol; 2014 Jul; 177(1):280-6. PubMed ID: 24588117
[TBL] [Abstract][Full Text] [Related]
18. Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations.
de Maat S; Björkqvist J; Suffritti C; Wiesenekker CP; Nagtegaal W; Koekman A; van Dooremalen S; Pasterkamp G; de Groot PG; Cicardi M; Renné T; Maas C
J Allergy Clin Immunol; 2016 Nov; 138(5):1414-1423.e9. PubMed ID: 27130860
[TBL] [Abstract][Full Text] [Related]
19. Clinical and laboratory characteristics that differentiate hereditary angioedema in 72 patients with angioedema.
Ohsawa I; Honda D; Nagamachi S; Hisada A; Shimamoto M; Inoshita H; Mano S; Tomino Y
Allergol Int; 2014 Dec; 63(4):595-602. PubMed ID: 25249065
[TBL] [Abstract][Full Text] [Related]
20. Ongoing contact activation in patients with hereditary angioedema.
Konings J; Cugno M; Suffritti C; Ten Cate H; Cicardi M; Govers-Riemslag JW
PLoS One; 2013; 8(8):e74043. PubMed ID: 24013493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]